The U.S. Department of Justice announced Wednesday it had closed criminal and civil investigations with Stamford-based Purdue Pharma and that the company had agreed to plead guilty to three federal criminal charges and pay more than $8 billion.

The resolution with the Big Pharma company, which has been under scrutiny from the federal government and dozens of attorneys general for how it marketed opioids, specifically OxyContin, is subject to the approval of a bankruptcy court.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]